Mendelian randomization links genetic endometriosis liability to increased placenta praevia risk
This Mendelian randomization meta-analysis investigated the causal effects of genetic liability to endometriosis on maternal and perinatal outcomes. It used summary-level GWAS data from multiple sources, including 60,674 endometriosis cases and 701,926 controls, with outcome data from the MR-PREG collaboration, FinnGen Release 12, and a postpartum haemorrhage GWAS meta-analysis. The analysis employed 41 independent genetic instruments for endometriosis liability.
The primary robust finding was a significant positive association with placenta praevia (OR 1.62, 95% CI 1.33-1.97; q<0.001). Estimates for premature placental separation and a broader placental disorders phenotype were directionally concordant but imprecise. For premature rupture of membranes, estimates were concordant across methods but sensitive to cohort exclusion and did not survive multiple testing correction. Estimates for hypertensive disorders, gestational diabetes, postpartum haemorrhage, stillbirth, and most neonatal outcomes were consistently close to the null across all analytical methods.
Safety and tolerability data were not reported. Key limitations of the study design and data were not explicitly detailed. The authors note that causal inference from standard observational studies is complicated by residual confounding, differential clinical management, and intermediate factors. The practice relevance is restrained, suggesting the findings may support more targeted surveillance for abnormal placentation in individuals with endometriosis rather than indicating a generalized elevation of obstetric risk.